Xu, Y.; Li, P.; Sun, S.; Chen, Y.; Feng, L.; Jiang, D.; Wan, C.; Li, J.; Cai, X.
Glycyrrhizinate Monoammonium Cysteine-Loaded Lipid Nanoparticles Allow for Improved Acute Liver Injury Therapy. Pharmaceutics 2025, 17, 90.
https://doi.org/10.3390/pharmaceutics17010090
AMA Style
Xu Y, Li P, Sun S, Chen Y, Feng L, Jiang D, Wan C, Li J, Cai X.
Glycyrrhizinate Monoammonium Cysteine-Loaded Lipid Nanoparticles Allow for Improved Acute Liver Injury Therapy. Pharmaceutics. 2025; 17(1):90.
https://doi.org/10.3390/pharmaceutics17010090
Chicago/Turabian Style
Xu, Yunjie, Pinghui Li, Shiran Sun, Yulin Chen, Lixia Feng, Dawei Jiang, Chidan Wan, Jianbo Li, and Xiong Cai.
2025. "Glycyrrhizinate Monoammonium Cysteine-Loaded Lipid Nanoparticles Allow for Improved Acute Liver Injury Therapy" Pharmaceutics 17, no. 1: 90.
https://doi.org/10.3390/pharmaceutics17010090
APA Style
Xu, Y., Li, P., Sun, S., Chen, Y., Feng, L., Jiang, D., Wan, C., Li, J., & Cai, X.
(2025). Glycyrrhizinate Monoammonium Cysteine-Loaded Lipid Nanoparticles Allow for Improved Acute Liver Injury Therapy. Pharmaceutics, 17(1), 90.
https://doi.org/10.3390/pharmaceutics17010090